Effects of unilateral 6-OHDA lesions on [3H]-N-propylnorapomorphine binding in striatum ex vivo and vulnerability to amphetamine-evoked dopamine release in rat.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Neurochemistry International

• Publication date

  2011-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.neuint.2010.12.007PMID 21163313
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Agonist binding fraction of dopamine D2/3 receptors in rat brain: a quantitative autoradiographic study.

  2010cited by this paper
• Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease.

  2009cited by this paper
• Evaluation of nigrostriatal damage and its change over weeks in a rat model of Parkinson's disease: small animal positron emission tomography studies with [(11)C]beta-CFT.

  2009cited by this paper
• Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo.

  2008cited by this paper
• Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients: Positron emission tomographic studies

  2006cited by this paper
• Measurement of the Proportion of D2 Receptors Configured in State of High Affinity for Agonists in Vivo: A Positron Emission Tomography Study Using [11C]N-Propyl-norapomorphine and [11C]Raclopride in Baboons

  2005cited by this paper
• Correlation between quantitative imaging and behavior in unilaterally 6-OHDA-lesioned rats.

  2005cited by this paper
• Changes in Dopamine D2 Receptors and 6-[18F]Fluoro-L-3,4-Dihydroxyphenylalanine Uptake in the Brain of 6-Hydroxydopamine- Lesioned Rats

  2004cited by this paper
• Density and affinity of the dopamine D2 receptors in aged symptomatic and asymptomatic MPTP‐treated monkeys: PET studies with [11C]raclopride

  2002cited by this paper
• In vivo PET studies of the dopamine D1 receptors in rhesus monkeys with long‐term MPTP‐induced Parkinsonism

  2002cited by this paper
• Specific Binding of [11C]Raclopride and N-[3H]Propyl-Norapomorphine to Dopamine Receptors in Living Mouse Striatum: Occupancy by Endogenous Dopamine and Guanosine Triphosphate–Free G Protein

  2002cited by this paper
• Imaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review

  2000cited by this paper
• Striatal D2 dopamine receptor status in Parkinson's disease: An [18F]dopa and [11C]Raclopride PET study

  1999cited by this paper
• Long-term behavioral and biochemical effects of 6-hydroxydopamine injections in rat caudate-putamen.

  1991cited by this paper
• Non-additivity of D2 receptor proliferation induced by dopamine denervation and chronic selective antagonist administration: evidence from quantitative autoradiography indicates a single mechanism of action.

  1989cited by this paper
• Heterogeneous distribution of dopamine D2 receptors within the rat striatum as revealed by autoradiography of [3H]N-n-propylnorapomorphine binding sites.

  1985cited by this paper
• In vivo binding of N-n-propylnorapomorphine in the rat striatum: quantification after lesions produced by kainate, 6-hydroxydopamine and decortication.

  1984cited by this paper

• [18F]F13640: a selective agonist PET radiopharmaceutical for imaging functional 5-HT1A receptors in humans

  2023cites this paper
• Synaptic Density and Neuronal Metabolic Function Measured by Positron Emission Tomography in the Unilateral 6-OHDA Rat Model of Parkinson’s Disease

  2021cites this paper
• Dorsal striatal dopamine induces fronto-cortical hypoactivity and attenuates anxiety and compulsive behaviors in rats

  2021cites this paper
• Dorsal striatal dopamine induces fronto-cortical hypoactivity and implies reduced anxiety and compulsive behaviors in rats

  2021cites this paper
• Synaptic density and neuronal metabolic function measured by PET in the unilateral 6-OHDA rat model of Parkinson’s disease

  2021cites this paper
• Is There a Role for GPCR Agonist Radiotracers in PET Neuroimaging?

  2019cites this paper
• University of Groningen Hunting for the high-affinity state of G-protein-coupled receptors with agonist tracers

  2019cites this paper
• Hunting for the high‐affinity state of G‐protein‐coupled receptors with agonist tracers: Theoretical and practical considerations for positron emission tomography imaging

  2018cites this paper
• Tritium-labelled alkaloids: Synthesis and applications.

  2017cites this paper
• Application of the Physical Disector Principle for Quantification of Dopaminergic Neuronal Loss in a Rat 6-Hydroxydopamine Nigral Lesion Model of Parkinson's Disease

  2017cites this paper
• Occupancy of pramipexole (Sifrol) at cerebral dopamine D2/3 receptors in Parkinson's disease patients

  2016cites this paper
• Recovery of dopamine transporters with methamphetamine detoxification is not linked to changes in dopamine release

  2015cites this paper
• Estudo dos efeitos neuroprotetor e antioxidante do óleo de peixe em modelo animal de doença de Parkinson

  2013cites this paper
• [18F]desmethoxyfallypride as a novel PET radiotracer for quantitative in vivo dopamine D2/D3 receptor imaging in rat models of neurodegenerative diseases.

  2012cites this paper
• Brain Imaging in Behavioral Neuroscience

  2012cites this paper
• Molecular imaging and the neuropathologies of Parkinson's disease.

  2012cites this paper
• Applications of positron emission tomography in animal models of neurological and neuropsychiatric disorders.

  2012cites this paper